Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News EACTS 2022

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Shelley Wood

October 12, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Industry News

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

July 23, 2019

News Conference News ESC Heart Failure 2019

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Shelley Wood

May 28, 2019

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

Advertisement

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

May 2023 News Roundup

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content